國立高雄大學圖資館 |

Language: English

Back

Structural insights into the mechanism and inhibition of prostaglandin H2 synthase-1.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Structural insights into the mechanism and inhibition of prostaglandin H2 synthase-1.
Author:	Gupta, Kushol.
Description:	254 p.
Notes:	Source: Dissertation Abstracts International, Volume: 64-06, Section: B, page: 2651.
Notes:	Supervisor: Patrick J. Loll.
Contained By:	Dissertation Abstracts International64-06B.
Subject:	Chemistry, Biochemistry.
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3095886
ISBN:	0496435116

Structural insights into the mechanism and inhibition of prostaglandin H2 synthase-1.
Gupta, Kushol.

Structural insights into the mechanism and inhibition of prostaglandin H2 synthase-1. [electronic resource] - 254 p.

Source: Dissertation Abstracts International, Volume: 64-06, Section: B, page: 2651.

Thesis (Ph.D.)--University of Pennsylvania, 2003.

Prostanoids are fatty acid autocoids that are involved in platelet aggregation, inflammation, and the pathophysiology of cardiovascular disease. Prostaglandin H2 synthase (PGHS; EC 1.14.99.1) is an important drug target essential to their formation. This bifunctional heme-dependent enzyme functions as a homodimer, where each monomer contains both a cyclooxygenase and a peroxidase active site. These active sites work in concert to transform arachidonic acid into PGH2, the precursor to the prostanoids. There are two known isoforms of this enzyme, which differ mainly in their expression patterns: PGHS-1 is a constitutively expressed isoform involved in "housekeeping" functions, while PGHS-2 expression is induced in response to inflammatory stimuli. Both isoforms are susceptible to inhibition by the class of drugs known as nonsteroidal antiinflammatory drugs (NSAIDs), which act by blocking the cyclooxygenase active site.

ISBN: 0496435116Subjects--Topical Terms:

226900
Chemistry, Biochemistry.

Structural insights into the mechanism and inhibition of prostaglandin H2 synthase-1.
LDR:02636nmm _2200265 _450 001 162059
005 20051017073406.5
008 230606s2003 eng d
020 $a 0496435116
035 $a 00148560
035 $a 162059
040 $a UnM $c UnM
100 0 $a Gupta, Kushol. $3 227165
245 1 0 $a Structural insights into the mechanism and inhibition of prostaglandin H2 synthase-1. $h [electronic resource]
300 $a 254 p.
500 $a Source: Dissertation Abstracts International, Volume: 64-06, Section: B, page: 2651.
500 $a Supervisor: Patrick J. Loll.
502 $a Thesis (Ph.D.)--University of Pennsylvania, 2003.
520 # $a Prostanoids are fatty acid autocoids that are involved in platelet aggregation, inflammation, and the pathophysiology of cardiovascular disease. Prostaglandin H2 synthase (PGHS; EC 1.14.99.1) is an important drug target essential to their formation. This bifunctional heme-dependent enzyme functions as a homodimer, where each monomer contains both a cyclooxygenase and a peroxidase active site. These active sites work in concert to transform arachidonic acid into PGH2, the precursor to the prostanoids. There are two known isoforms of this enzyme, which differ mainly in their expression patterns: PGHS-1 is a constitutively expressed isoform involved in "housekeeping" functions, while PGHS-2 expression is induced in response to inflammatory stimuli. Both isoforms are susceptible to inhibition by the class of drugs known as nonsteroidal antiinflammatory drugs (NSAIDs), which act by blocking the cyclooxygenase active site.
520 # $a The goal of this dissertation was to use x-ray crystallography to expand the current understanding of the structure of PGHS. In doing so, key issues, including the structural consequences of peroxidase impairment by protoporphyrin substitution and the structural basis of NSAID binding were investigated. As a result of this study, six unique x-ray crystal structures of PGHS were determined. Among these structures, the first high-resolution (2.0 A) structures of PGHS-1 were solved, and together these structures yield insights into the architecture of the two active sites of PGHS, the nature of inhibitor binding in the cyclooxygenase active site, and the structural consequences of protoporphyrin substitution.
590 $a School code: 0175.
650 # 0 $a Chemistry, Biochemistry. $3 226900
650 # 0 $a Health Sciences, Pharmacology. $3 227166
710 0 # $a University of Pennsylvania. $3 212781
773 0 # $g 64-06B. $t Dissertation Abstracts International
790 $a 0175
790 1 0 $a Loll, Patrick J., $e advisor
791 $a Ph.D.
792 $a 2003
856 4 0 $u http://libsw.nuk.edu.tw/login?url=http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3095886 $z http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3095886